Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells.

Zhang YL, Zhang ZH, Jiang TY, Ayman-Waddad, Jing-Li, Lv HX, Zhou JP.

Pharmazie. 2013 Jan;68(1):47-53.

PMID:
23444780
2.

[In situ rat intestine absorption of paclitaxel-loaded solid lipid nanoparticles modified with cell-penetrating peptides].

Li CC, Zhang ZH, Zhang YL, Lü HX, Zhou JP.

Yao Xue Xue Bao. 2013 Jan;48(1):131-7. Chinese.

PMID:
23600154
3.

Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.

Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S.

Int J Pharm. 2008 Feb 4;348(1-2):137-45. Epub 2007 Jul 18.

PMID:
17714896
4.

Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.

Baek JS, Cho CW.

Int J Pharm. 2015 Jan 30;478(2):617-24. doi: 10.1016/j.ijpharm.2014.12.018. Epub 2014 Dec 12.

PMID:
25510604
5.

2-Hydroxypropyl-β-cyclodextrin-modified SLN of paclitaxel for overcoming p-glycoprotein function in multidrug-resistant breast cancer cells.

Baek JS, Cho CW.

J Pharm Pharmacol. 2013 Jan;65(1):72-8. doi: 10.1111/j.2042-7158.2012.01578.x. Epub 2012 Aug 13.

PMID:
23215690
6.

Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.

Chirio D, Gallarate M, Peira E, Battaglia L, Muntoni E, Riganti C, Biasibetti E, Capucchio MT, Valazza A, Panciani P, Lanotte M, Annovazzi L, Caldera V, Mellai M, Filice G, Corona S, Schiffer D.

Eur J Pharm Biopharm. 2014 Nov;88(3):746-58.

7.

Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.

Song N, Liu W, Tu Q, Liu R, Zhang Y, Wang J.

Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):454-63. doi: 10.1016/j.colsurfb.2011.06.009. Epub 2011 Jun 15.

PMID:
21719259
8.

Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.

Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R.

Eur J Pharm Biopharm. 2012 Jun;81(2):248-56. doi: 10.1016/j.ejpb.2012.03.004. Epub 2012 Mar 14.

PMID:
22446630
9.

In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.

Gao C, Pan J, Lu W, Zhang M, Zhou L, Tian J.

Anticancer Drugs. 2009 Oct;20(9):807-14. doi: 10.1097/CAD.0b013e328330c811.

PMID:
19696655
10.

Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.

Lee MK, Lim SJ, Kim CK.

Biomaterials. 2007 Apr;28(12):2137-46. Epub 2007 Jan 10.

PMID:
17257668
11.

Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.

Pandey V, Gajbhiye KR, Soni V.

Drug Deliv. 2015 Feb;22(2):199-205. doi: 10.3109/10717544.2013.877100. Epub 2014 Jan 27.

PMID:
24467582
12.

Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics.

Videira MA, Arranja AG, Gouveia LF.

Eur J Pharm Sci. 2013 May 13;49(2):302-10. doi: 10.1016/j.ejps.2013.03.005. Epub 2013 Mar 23.

PMID:
23528739
13.

In vitro cytotoxic activity of cationic paclitaxel nanoparticles on MDR-3T3 cells.

Niu G, Castro CH, Nguyen N, Sullivan SM, Hughes JA.

J Drug Target. 2010 Jul;18(6):468-76. doi: 10.3109/10611860903508804.

PMID:
20059301
14.

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel.

Feng SS, Mu L, Win KY, Huang G.

Curr Med Chem. 2004 Feb;11(4):413-24.

PMID:
14965222
15.

[In vitro and in vivo study of two kinds of long-circulating solid lipid nanoparticles containing paclitaxel].

Chen DB, Yang TZ, Lu WL, Zhang Q.

Yao Xue Xue Bao. 2002 Jan;37(1):54-8. Chinese.

PMID:
12579901
16.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.

PMID:
20934500
17.

Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles.

Guo X, Xing Y, Mei Q, Zhang H, Zhang Z, Cui F.

Anticancer Drugs. 2012 Feb;23(2):185-90. doi: 10.1097/CAD.0b013e32834cf8d0.

PMID:
22027535
18.
19.

Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.

Wang F, Li L, Liu B, Chen Z, Li C.

Biomed Pharmacother. 2017 Feb;86:595-604. doi: 10.1016/j.biopha.2016.12.041. Epub 2016 Dec 24.

PMID:
28027535
20.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123

Supplemental Content

Support Center